Reversion Compound definition

Reversion Compound means NLG919, any Next Generation Compound or any Subsequent Compound.

Reversion Compound means any Compound with respect to which this Agreement is terminated.

Reversion Compound means [***]

Examples of Reversion Compound in a sentence

• Sanofi may only include in the Backup Research Plan any Reversion Compounds which are not subject to Pre-Existing Restrictions at the time the Backup Research Plan is prepared; thereafter, any such Reversion Compound will no longer be classified as a “Reversion Compound” and instead will be classified as a “Collaboration Compound” under the Backup Research Plan.

• NGM shall have the right to sublicense the license under Section 13.6.2(c) to a manufacturer designated by NGM and reasonably acceptable to Merck with respect to the right to make and have made the Reversion Product and/or Reversion Compound for the purpose of NGM exercising the license granted to NGM under Section 13.6.2(c) and Merck shall promptly thereafter [*] and shall execute such additional documents as is reasonably necessary to effectuate the intent of the foregoing Section 13.6.2(i).

• Upon delivery of such notice, such Collaboration Compound shall be deemed a Reversion Compound and Gilead thereafter shall have no rights or license of any kind under this Agreement to such designated Collaboration Compound.

• If such OncoMed Reversion Compound is designated as such by reason of a termination under Section 11.2 (by Celgene), Section 11.3 or Section 11.4 (by Celgene), OncoMed shall [***]of (a) [***], provided that [***].

• ALSO NOTE THAT CARRIER ANTI-SPAM ENGINES MIGHT BLOCK MESSAGES WHICH INCLUDE URL SHORTENING LINKS.

• In partial consideration for having granted the foregoing license and because [***], NGM shall pay to Merck a royalty on worldwide Net Sales (applied mutatis mutandis) for such NP201 Reversion Compound or NP201 Reversion Products at a rate of [***].

• Gilead shall have no obligation to pay for Patent Costs for Patents on Reversion Compounds, incurred after the particular Collaboration Compound become a Reversion Compound.

More Definitions of Reversion Compound

Reversion Compound means, subject to Section 13.7, solely: (a) in the case of termination of one or more Option Compounds or Option Products, all Optioned Compound(s) associated with the relevant Merck Option [*]; or (b) in the case of termination of the NP201 Program, all NP201 Compound(s), as applicable, in each case of clauses (a) and (b), existing (i.e., identified or generated) as of the time of delivery of a notice of termination with respect thereto (by Merck under Section 13.2.2, 13.2.4 or 13.2.5 or by NGM under Section 13.5) and/or, in the case of the NP201 Program, notice of discontinuation (pursuant to Section 3.5.3) hereunder; provided, however, that in all cases Reversion Compounds shall exclude any Merck proprietary compound that is not a Program Compound including any and all Small Molecule Collaboration Compounds (“Merck Proprietary Compound”).

Reversion Compound means a Collaboration Compound Directed Against a Terminated Target for which the Parties have submitted a [**] pursuant to Section 3.6 (other than any Novartis Internal Collaboration Compound).

Reversion Compound means, with respect to a Terminated Program, the Collaboration Compounds or Licensed Compounds, as applicable, that are the subject of such Terminated Program.

Reversion Compound will have the meaning ascribed to such term in Section 3.2(a).

Reversion Compound means a Licensed Compound; provided, however, that in all cases, Reversion Compounds shall exclude any Licensed Compounds, which, in EQRx’s reasonable opinion, would be unsafe for Exploitation.

Reversion Compound means, subject to Section 13.7, solely: (a) in the case of termination of one or more Optioned Compounds or Optioned Products, all Optioned Compound(s) associated with the relevant Merck Option [***]; or (b) in the case of termination of the NP201 Program, all NP201 Compound(s), as applicable, in each case of clauses (a) and (b), existing (i.e., identified or generated) as of the time of delivery of a notice of termination with respect thereto (by Merck under Section 13.2.4 or 13.2.5 (or Section 13.2.2 of the Original Agreement) or by NGM under Section 13.5); provided, however, that in all cases Reversion Compounds shall exclude any Merck proprietary compound that is not a Program Compound including any and all Small Molecule Collaboration Compounds (“Merck Proprietary Compound”).